483
Vetter Pharma Fertigung GmbH & Co. KGFDA 483 - Vetter Pharma Fertigung GmbH & Co. KG - November 02, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Vetter Pharma-Fertigung GmbH & Co. KG in Langenargen, Germany, revealed two significant observations. The firm failed to thoroughly review unexplained discrepancies, specifically regarding defects found during visual inspection of reference or retention samples. Additionally, the procedure for identifying in-progress drug product samples was not clearly described in their SOP.
Open in Dashboard
ID · 58a47cca-e9e3-4e53-8f4a-ae3cc5f6d64b